ArticleJAMA network open2025
Packaging of Cannabis Edibles, Health Warning Recall, and Perceptions Among Young Adults.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Relative Preference of Cannabis, Alcohol, and Nicotine Products Among U.S. Adolescents and Young Adults Who Are Using or Susceptible to Cannabis Use: Insights from a Best-Worst Scaling Study.Substance use & misuse · 2026Article
- Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis.Addiction (Abingdon, England) · 2026Article
- Perceptions of Cannabis Vaping Advertising Messages and Warnings Among US Young Adults.Substance use & addiction journal · 2026Article
- International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?Drug and alcohol review · 2026Review
- Impact of Simple Versus Complex Cannabis Advertising Messages and Warnings on US Young Adults' Product Perceptions.Substance use & addiction journal · 2026Article
- Effects of textual warnings and warning symbols on cannabis advertisements on product perceptions among US young adults.Health education research · 2026Article
- Perceptions of cannabis warnings and recommendations for improvement: a qualitative study with people who use cannabis from the United States.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Importance: Cannabis edibles have increased in popularity, particularly among young adults and in states with recreational cannabis legalization. Little is known about the association of cannabis packaging regulations with health warning recall and perceptions. Objective: To evaluate whether features of packaging are associated with ability to recall health warnings as well as perceptions of cannabis edible products among young adults. Design, Setting, and Participants: This cross-sectional study was conducted from October 6 to 18, 2023, in 23 states and Washington, DC, that legalized recreational cannabis. Participants included young adults aged 18 to 29 years, including cannabis users and nonusers. Exposures: In the between-individual 3 (packaging styles) × 3 (health claims) × 7 (health warning themes) full-factorial randomized online experiment, participants viewed an image of the packaging of cannabis edible products with random variations in package styles (plain, normal branded, and youth-appealing packaging), health claims (none, pain relief, and sleep aid), and health warning themes (long-lasting effects, pregnancy-related harms, driving impairment, mental health problems, harms to youths, harms of high potency products, and delayed effects). Main Outcomes and Measures: Five self-reported outcomes, including warning recall (ability to correctly recall the warning label shown), product appeal rating, relative harm, adult-oriented appearance, and target age group. Results: Participants comprised 4500 young adults aged 18 to 29 years, including 3000 cannabis users and 1500 nonusers. These participants included 2287 men (50.8%); 1095 participants (24.3%) were aged 18 to 20 years, and 1905 (42.3%) were aged 21 to 25 years. Compared with normal branded packaging, plain packaging was associated with increased odds of correct warning recall (correct rate, 52.9%; odds ratio [OR], 1.47 [95% CI, 1.27-1.70]), decreased appeal ratings (mean appeal rating, 5.2 of 10; OR, 0.70 [95% CI, 0.61-0.80]), and increased perceived relative harm (mean harm rating, 2.6 of 5; OR, 1.48 [95% CI, 1.27-1.74]). Compared with normal branded packaging, youth-appealing packaging was associated with increased appeal ratings (OR, 1.40 [95% CI, 1.20-1.64]), particularly among younger adults aged 18 to 20 years. Compared with no health claims, the pain relief and sleep aid claims were associated with increased appeal ratings (pain relief: OR, 1.31 [95% CI, 1.17-1.46]; sleep aid: OR, 1.36 [95% CI, 1.24-1.50]), particularly among past-year nonusers. Conclusions and Relevance: Results of this cross-sectional study of the features of cannabis edible packaging suggested that requiring plain packaging, prohibiting youth-appealing features, and regulating unsubstantiated health claims may improve warning recall and accurate harm perceptions among young adults. Future observational studies evaluating the effects of these regulations are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.